With the cost of healthcare skyrocketing and increased scrutiny of government insurance programs, state Medicaid systems are under more pressure than ever before to rein in costs while improving the quality of care of those they cover.
Our solutions simultaneously improve costs and patient outcomes by streamlining the prescription drug prior authorization process for Medicaid pharmacy and promoting appropriate, effective, and safe use of prescription drugs among its patient population.
Infina Connect’s cloud-based solutions assist Medicaid Pharmacies in two key ways:
Accelerate approvals process and ensure patient wait time for appropriate drug therapy is minimized.
Automate many of the rules and processes that are handled manually and through phone, fax and paper today.
Eliminate errors caused by manual processes, and ensure those being prescribed potentially harmful drugs are monitored by their providers in accordance with clinical best practices.
To confront issues of rising costs and efforts to improve the quality of care for children in the Medicaid system, Infina partnered with AccessCare to develop innovative solutions for the North Carolina Medicaid population. Using its cloud-based application platform, Infina developed “A+KIDS” (Antipsychotics – Keeping It Documented for Safety), a first-of-its-kind cloud-based solution to help providers appropriately prescribe antipsychotic drugs for children and then monitor them in accordance with clinical best practices. This, in turn, helps to reduce unnecessary prescribing of such drugs and improves outcomes.
Using Infina’s technology, NC Medicaid has been able to:
Infina’s other innovative electronic prior authorization solutions include:
A cloud-based solution that allows a provider to receive real-time approval when prescribing Synagis, an expensive specialty drug, for a patient as long as the drug’s strict prescribing guidelines are met. It also automatically calculates each patient’s dose based on weight information provided, minimizing wastage.
Automated prior authorization and monitoring of antipsychotic drug use in kids to promote clinical best practices and reduce overprescribing to children.
A cloud-based application that allows a provider to request a brand name medication for a patient when deemed “Medically Necessary” and then document the adverse effect related to the generic equivalent at the same time.